# Primus Therapeutics Inc.: Form D filings

Primus Therapeutics Inc., a pharmaceuticals company in Skillman, NJ, filed 2 Form D notices with the SEC in 2011. The latest, on February 16, 2011, reports $300,000 sold of a $1 million offering to 2 investors.

Find out what Primus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Primus%20Therapeutics%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Primus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprimus-therapeutics-inc-1501467)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Primus%20Therapeutics%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Primus%20Therapeutics%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprimus-therapeutics-inc-1501467)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 23 ORCHARD ROAD, Suite 105, Skillman, NJ, 08558
- Phone: (800) 903-4131
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2010
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1501467

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 16, 2011 | New notice | $1,000,000 | $300,000 | $700,000 | 2 | Jan 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1501467/000150146711000002/0001501467-11-000002-index.htm) |
| Feb 16, 2011 | New notice | $500,000 | $500,000 | $0 | 4 | Jul 12, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1501467/000150146711000001/0001501467-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Mark Massad | Executive Officer |  |
| Andrew Sadosky | Director |  |
| Joseph Falsetti | Director |  |
| Dennis O'Donnell | Executive Officer, Director |  |
| Robert Hariri | Director |  |
| Kenneth Taylor | Director |  |

## Other pharmaceuticals companies in New Jersey that filed recently

- [Grace Therapeutics, Inc.](https://specstream.ai/data/form-d/company/grace-therapeutics-inc-1444192) $10 million · Aug 11, 2026

[Every Form D from the week of Feb 14, 2011](https://specstream.ai/data/form-d/week/2011-02-14) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Primus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).